Spectrum and prevalence of cardiac ryanodine receptor (RyR2) mutations in a cohort of unrelated patients referred explicitly for long QT syndrome genetic testing
- 29 July 2005
- journal article
- research article
- Published by Elsevier in Heart Rhythm
- Vol. 2 (10), 1099-1105
- https://doi.org/10.1016/j.hrthm.2005.07.012
Abstract
No abstract availableKeywords
Funding Information
- CJ Foundation for SIDS
- Doris Duke Charitable Foundation
- Mayo Foundation for Medical Education and Research
- American Heart Association
- National Institutes of Health (HD42569)
- Dr. Scholl Foundation
This publication has 31 references indexed in Scilit:
- Pathogenesis of Unexplained Drowning: New Insights From a Molecular AutopsyMayo Clinic Proceedings, 2005
- Targeted Mutational Analysis of the RyR2-Encoded Cardiac Ryanodine Receptor in Sudden Unexplained Death: A Molecular Autopsy of 49 Medical Examiner/Coroner's CasesMayo Clinic Proceedings, 2004
- Spectrum and Frequency of Cardiac Channel Defects in Swimming-Triggered Arrhythmia SyndromesCirculation, 2004
- Ethnic Differences in Cardiac Potassium Channel Variants: Implications for Genetic Susceptibility to Sudden Cardiac Death and Genetic Testing for Congenital Long QT SyndromeMayo Clinic Proceedings, 2003
- PKA Phosphorylation Dissociates FKBP12.6 from the Calcium Release Channel (Ryanodine Receptor)Cell, 2000
- The Long QT Syndrome: Ion Channel Diseases of the HeartMayo Clinic Proceedings, 1998
- Mutations in the hminK gene cause long QT syndrome and suppress lKs functionNature Genetics, 1997
- Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmiasNature Genetics, 1996
- A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndromeCell, 1995
- The Spectrum of Symptoms and QT Intervals in Carriers of the Gene for the Long-QT SyndromeNew England Journal of Medicine, 1992